|
|
||||||||
Journal of Neurophysiology, Vol 76, Issue 4 2691-2700, Copyright © 1996 by APS
ARTICLES |
M. A. Abdul-Ghani, T. A. Valiante, P. L. Carlen and P. S. Pennefather
Medical Research Council Nerve Cell and Synapse Group, Faculty of Pharmacy, Playfair Neuroscience Unit Toronto Hospital Research Institute, Ontario, Canada.
1. Whole cell recordings from dentate granule neurons in the hippocampal slice preparation reveal that (1 S, 3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD), a selective agonist at metabotropic glutamate receptors (mGluRs), inhibits a calcium-activated potassium current (IAHP) responsible for the postspike after-hyperpolarization. Inclusion of 1 mM of the Ca2+ chelator ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid in the patch pipette reduced the inhibitory action of ACPD on IAHP while having no effect on a similar action of serotonin (5-HT). Thus the known action of ACPD of mobilizing intracellular Ca2+ may be involved in this inhibitor action of ACPD. 2. Inhibition of IAHP is not secondary to effects on Ca2+ currents, because 10 microM ACPD, which inhibits IAHP by 95 +/- 5% (mean +/- SE), reduced the Ca2+ current by only 8 +/- 4%. 3. Activation of mGluRs accelerates the irreversible inhibition of IAHP that develops when 88 microM GTP-gamma-S is included in the pipette filling solution, whereas inclusion of 1 mM GDP-beta-S attenuated the inhibitory action of ACPD. These results indicate that the response to mGluR activation is G protein mediated. 4. Group I mGluRs, which includes mGluR1 and mGluR5, are G-protein-coupled receptors that are known to stimulate phospholipase C (PLC)-mediated hydrolysis of phosphoinositides to produce 1,4,5-triphosphate (IP3), which in turn is known to mobilize the release of intracellular Ca2+. The weak but selective mGluR1 agonist (S)-3-hydroxyphenylglycine (100 microM) completely inhibited IAHP, and the mGluR1 antagonist (S)-4-carboxyphenylglycine (500 microM) reduced IAHP inhibition produced by 5 microM ACPD from 73 +/- 6% to 22 +/- 4%. These results indicate that the mGluR responsible for IAHP inhibition has a similar pharmacological profile to that of those coupled to IP3 production. 5. The effects of agents known to interfere with IP3 production and action also support IP3 involvement in ACPD action. Neomycin (1 mM in pipette solution), which should reduce IP3 production through inhibition of PLC, reduced the ability of 10 microM ACPD to inhibit IAHP from almost 100% to 57 +/- 8% (n = 8). Heparin, an IP3 receptor antagonist that reduces Ca2+ mobilization, attenuated the inhibitory action 10 microM ACPD from almost 100% to 39 +/- 5% (n = 5). Heparin by itself increased the amplitude and duration of IAHP, suggesting that resting levels of IP3 are sufficient to suppress of IAHP partially. 6. In addition to the pool of intracellular Ca2+ that is mobilized by IP3, there is a distinct pool that is responsible for Ca(2+)-triggered Ca2+ release and is blocked by ryanodine or dantrolene. These drugs caused a small reduction of both IAHP and the inhibitory action of ACPD. Possibly the Ca2+ signal mobilized by IP3 is partially amplified by Ca2+ released from the ryanodine-sensitive stores. 7. Activation of PLC can also lead to the production of diacylglycerol and activation of protein kinase C (PKC). However, the inhibitory action of ACPD on IAHP was not affected by staurosporine at a concentration (1 microM) that inhibits both protein kinase A (PKA) and PKC and blocks the action of 5-HT to inhibit IAHP. 8. Activation of PKA by the adenylate cyclase activator forskolin led to inhibition of IAHP. Although activation of mGluR1 agonists can also stimulate adenylate cyclase and activate PKA, inhibition of PKA and the effect of forskolin on IAHP with the Walsh peptide did not affect ACPD inhibition of IAHP. 9. All of our results support the hypothesis that mGluR-mediated inhibition of IAHP is initiated by the production of IP3 and the mobilization of intracellular Ca2+.
This article has been cited by other articles:
![]() |
J. H. Caldwell, G. A. Herin, G. Nagel, E. Bamberg, A. Scheschonka, and H. Betz Increases in Intracellular Calcium Triggered by Channelrhodopsin-2 Potentiate the Response of Metabotropic Glutamate Receptor mGluR7 J. Biol. Chem., September 5, 2008; 283(36): 24300 - 24307. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Young, R. Bianchi, and R. K. S. Wong Signaling Mechanisms Underlying Group I mGluR-Induced Persistent AHP Suppression in CA3 Hippocampal Neurons J Neurophysiol, March 1, 2008; 99(3): 1105 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Sohn, D. Lee, H. Cho, W. Lim, H.-S. Shin, S.-H. Lee, and W.-K. Ho Receptor-specific inhibition of GABAB-activated K+ currents by muscarinic and metabotropic glutamate receptors in immature rat hippocampus J. Physiol., April 15, 2007; 580(2): 411 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Sekizawa and A. C. Bonham Group I Metabotropic Glutamate Receptors on Second-Order Baroreceptor Neurons Are Tonically Activated and Induce a Na+-Ca2+ Exchange Current J Neurophysiol, February 1, 2006; 95(2): 882 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Young, S.-C. Chuang, and R. K. S. Wong Modulation of afterpotentials and firing pattern in guinea pig CA3 neurones by group I metabotropic glutamate receptors J. Physiol., January 15, 2004; 554(2): 371 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Ireland and W. C. Abraham Group I mGluRs Increase Excitability of Hippocampal CA1 Pyramidal Neurons by a PLC-Independent Mechanism J Neurophysiol, July 1, 2002; 88(1): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krause, S. Offermanns, M. Stocker, and P. Pedarzani Functional Specificity of Galpha q and Galpha 11 in the Cholinergic and Glutamatergic Modulation of Potassium Currents and Excitability in Hippocampal Neurons J. Neurosci., February 1, 2002; 22(3): 666 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-T. Jin, C. J. Beaver, Q. Ji, and N. W. Daw Effect of the Group I Metabotropic Glutamate Agonist DHPG on the Visual Cortex J Neurophysiol, October 1, 2001; 86(4): 1622 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mannaioni, M. J. Marino, O. Valenti, S. F. Traynelis, and P. J. Conn Metabotropic Glutamate Receptors 1 and 5 Differentially Regulate CA1 Pyramidal Cell Function J. Neurosci., August 15, 2001; 21(16): 5925 - 5934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Brodie, M. A. McElvain, E. B. Bunney, and S. B. Appel Pharmacological Reduction of Small Conductance Calcium-Activated Potassium Current (SK) Potentiates the Excitatory Effect of Ethanol on Ventral Tegmental Area Dopamine Neurons J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 325 - 333. [Abstract] [Full Text] |
||||
![]() |
A. Meir, S. Ginsburg, A. Butkevich, S. G. Kachalsky, I. Kaiserman, R. Ahdut, S. Demirgoren, and R. Rahamimoff Ion Channels in Presynaptic Nerve Terminals and Control of Transmitter Release Physiol Rev, July 1, 1999; 79(3): 1019 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Carlson, M. L. Slawecki, E. Lancaster, and A. Keller Distribution and Activation of Intracellular Ca2+ Stores in Cultured Olfactory Bulb Neurons J Neurophysiol, October 1, 1997; 78(4): 2176 - 2185. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |